Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL1900021	PDR001注射用浓溶液	spartalizumab	Injection	Biological Products	Import Drug Application	2019-02-25	诺华（中国）生物医学研究有限公司	China Novartis Institutes For Biomedical Research Co Ltd	In Review	2019-02-23	view
JXSL1900101	PDR001注射用浓溶液	spartalizumab	Injection	Biological Products	Import Drug Application	2019-09-29	诺华（中国）生物医学研究有限公司	China Novartis Institutes For Biomedical Research Co Ltd	In Review	2019-09-28	view
JXSL2000094	PDR001注射用浓溶液	spartalizumab	Injection	Biological Products	Import Drug Application	2020-07-03	诺华（中国）生物医学研究有限公司	China Novartis Institutes For Biomedical Research Co Ltd	In Review	2020-07-02	view